Market Update: Adaptive Biotechnologies Corp (ADPT) Sees Positive Movement, Closing at 4.69

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Adaptive Biotechnologies Corp (NASDAQ: ADPT) closed at $4.69 up 7.32% from its previous closing price of $4.37. In other words, the price has increased by $7.32 from its previous closing price. On the day, 2.33 million shares were traded. ADPT stock price reached its highest trading level at $4.7 during the session, while it also had its lowest trading level at $4.29.

Ratios:

For a deeper understanding of Adaptive Biotechnologies Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.38 and its Current Ratio is at 3.52. In the meantime, Its Debt-to-Equity ratio is 1.00 whereas as Long-Term Debt/Eq ratio is at 0.96.

On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.

Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 18 ’24 when PISKEL KYLE sold 248 shares for $4.98 per share. The transaction valued at 1,235 led to the insider holds 154,330 shares of the business.

Taylor Stacy L sold 26,922 shares of ADPT for $121,079 on Aug 22 ’24. The SVP and General Counsel now owns 139,365 shares after completing the transaction at $4.50 per share. On Aug 22 ’24, another insider, STACY L TAYLOR, who serves as the Officer of the company, bought 26,922 shares for $4.50 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 692145536 and an Enterprise Value of 673144768. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.19 while its Price-to-Book (P/B) ratio in mrq is 3.09. Its current Enterprise Value per Revenue stands at 3.797 whereas that against EBITDA is -4.581.

Stock Price History:

Over the past 52 weeks, ADPT has reached a high of $6.70, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is -5.50%, while the 200-Day Moving Average is calculated to be 17.27%.

Shares Statistics:

For the past three months, ADPT has traded an average of 1.05M shares per day and 1534440 over the past ten days. A total of 145.08M shares are outstanding, with a floating share count of 142.73M. Insiders hold about 3.29% of the company’s shares, while institutions hold 92.16% stake in the company. Shares short for ADPT as of 1730332800 were 8963251 with a Short Ratio of 8.52, compared to 1727654400 on 9914248. Therefore, it implies a Short% of Shares Outstanding of 8963251 and a Short% of Float of 7.8.

Most Popular